Intracellular nucleic acid sensors and autoimmunity

Journal of Interferon and Cytokine Research

Volumn 31, Issue 12, 2011, Pages 867-886

  Theofilopoulos, Argyrios N ^a   Kono, Dwight H ^a   Beutler, Bruce ^a   Baccala, Roberto ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INFLAMMASOME; NUCLEIC ACID; PROTEINASE; RNA; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOSENSOR; CYTOSOL; HUMAN; MEMBRANE MICROPARTICLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CYTOSOL; HUMANS; MODELS, IMMUNOLOGICAL; NUCLEIC ACIDS; ORGANELLES; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 83455200891     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0092     Document Type: Review

References (241)

1. Ablasser A, Bauernfeind F, Hartmann G, Latz E, Fitzgerald KA, Hornung V. 2009. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10(10):1065-1072.
2. Allam R, Pawar RD, Kulkarni OP, Hornung V, Hartmann G, Segerer S, Akira S, Endres S, Anders HJ. 2008. Viral 5'-tri-phosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses. Eur J Immunol 38(12):3487-3498.
3. Allen IC, Moore CB, Schneider M, Lei Y, Davis BK, Scull MA, Gris D, Roney KE, Zimmermann AG, Bowzard JB, Ranjan P, Monroe KM, Pickles RJ, Sambhara S, Ting JP. 2011. NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways. Immunity 34(6):854-865.
4. Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG, Iversen L, Arthur JS. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 9(9):1028-1036.
5. Andersson U, Rauvala H. 2011. Introduction: HMGB1 in inflammation and innate immunity. J Intern Med 270(4): 296-300.
6. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober HJ, Okamoto K, Nishikawa K, Latz E, Golenbock DT, Aoki K, Ohya K, Imai Y, Morishita Y, Miyazono K, Kato S, Saftig P, Takayanagi H. 2008. Cathepsin K-dependent Toll-like receptor 9 signaling revealed in experimental arthritis. Science 319(5863):624-627. (Pubitemid 351197065)
7. Baccala R, Gonzalez-Quintial R, Lawson BR, Stern ME, Kono DH, Beutler B, Theofilopoulos AN. 2009. Sensors of the innate immune system: their mode of action. Nat Rev Rheumatol 5(8):448-456.
8. Baccala R, Hoebe K, Kono DH, Beutler B, Theofilopoulos AN. 2007. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med 13(5):543-551. (Pubitemid 46828489)
9. Baccala R, Kono DH, Theofilopoulos AN. 2005. Interferons as pathogenic effectors in autoimmunity. Immunol Rev 204:9-26. (Pubitemid 40460490)
10. Baechler EC, Gregersen PK, Behrens TW. 2004. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 16(6):801-807. (Pubitemid 39423672)
11. Banchereau J, Pascual V. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25(3):383-392. (Pubitemid 44354221)
12. Barbalat R, Ewald SE, Mouchess ML, Barton GM. 2011. Nucleic acid recognition by the innate immune system. Annu Rev Immunol 29:185-214.
13. Barber GN. 2011. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr Opin Immunol 23(1):10-20.
14. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V. 2003. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197(6): 711-723. (Pubitemid 36350866)
15. Beutler B. 2009. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227(1):248-263.
16. Beutler B, Jiang Z, Georgel P, Crozat K, Croker B, Rutschmann S, Du X, Hoebe K. 2006. GENETIC analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu Rev Immunol 24:353-389.
17. Bhardwaj RK, Herrera-Ruiz D, Eltoukhy N, Saad M, Knipp GT. 2006. The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells. Eur J Pharm Sci 27(5):533-542. (Pubitemid 43363344)
18. Bianchi ME, Manfredi AA. 2007. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev 220:35-46. (Pubitemid 350045574)
19. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB. 1999. Serum amyloid P component controls chro-matin degradation and prevents antinuclear autoimmunity. Nat Med 5(6):694-697. (Pubitemid 29289434)
20. Blasius AL, Arnold CN, Georgel P, Rutschmann S, Xia Y, Lin P, Ross C, Li X, Smart NG, Beutler B. 2010. Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Tolllike receptor signaling in plasmacytoid dendritic cells. Proc Natl Acad Sci USA 107(46):19973-19978.
21. Blasius AL, Beutler B. 2010. Intracellular Toll-like receptors. Immunity 32(3):305-315.
22. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, Kalwani M, Garcia-Flores Y, Luong M, Devrekanli A, Xu J, Sun G, Tay J, Linsley PS, Baltimore D. 2011. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208(6):1189-1201.
23. Bossu P, Neumann D, Del Giudice E, Ciaramella A, Gloaguen I, Fantuzzi G, Dinarello CA, Di Carlo E, Musiani P, Meroni PL, Caselli G, Ruggiero P, Boraschi D. 2003. IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. Proc Natl Acad Sci USA 100(24):14181-14186. (Pubitemid 37499211)
24. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19(1):56-59. (Pubitemid 28242023)
25. Braun D, Geraldes P, Demengeot J. 2003. Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice. J Autoimmun 20(1):15-25. (Pubitemid 36207624)
26. Brinkmann MM, Spooner E, Hoebe K, Beutler B, Ploegh HL, Kim YM. 2007. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 177(2):265-275. (Pubitemid 46658638)
27. Burckstummer T, Baumann C, Bluml S, Dixit E, Durnberger G, Jahn H, Planyavsky M, Bilban M, Colinge J, Bennett KL, Su-perti-Furga G. 2009. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the in-flammasome. Nat Immunol 10(3):266-272.
28. Casciola-Rosen LA, Anhalt G, Rosen A. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179(4):1317-1330. (Pubitemid 24091790)
29. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Senechal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Heron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova JL. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314(5797):308-312. (Pubitemid 44571977)
30. Chaturvedi A, Dorward D, Pierce SK. 2008. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 28(6):799-809.
31. Chiu YH, Macmillan JB, Chen ZJ. 2009. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138(3):576-591.
32. Chockalingam A, Brooks JC, Cameron JL, Blum LK, Leifer CA. 2009. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol Cell Biol 87(3):209-217.
33. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med 202(2):321-331. (Pubitemid 41043827)
34. Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25(3):417-428. (Pubitemid 44354217)
35. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T. 2008. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14(4):399-406. (Pubitemid 351499388)
36. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196(1):135-140. (Pubitemid 34747319)
37. Coll RC, O'Neill LA. 2010. New insights into the regulation of signalling by Toll-like receptors and nod-like receptors. J Innate Immun 2(5):406-421.
38. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. 1999. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58(5):309-314. (Pubitemid 29232144)
39. Croker BA, Lawson BR, Berger M, Eidenschenk C, Blasius AL, Moresco EM, Sovath S, Cengia L, Shultz LD, Theofilopoulos AN, Pettersson S, Beutler BA. 2008. Inflammation and auto-immunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc Natl Acad Sci USA 105(39):15028-15033.
40. Crow YJ, Hayward BE, Parmar R, Robins P, Leitch A, Ali M, Black DN, van Bokhoven H, Brunner HG, Hamel BC, Corry PC, Cowan FM, Frints SG, Klepper J, Livingston JH, Lynch SA, Massey RF, Meritet JF, Michaud JL, Ponsot G, Voit T, Lebon P, Bonthron DT, Jackson AP, Barnes DE, Lindahl T. 2006a. Mutations in the gene encoding the 3'-5' DNA exonu-clease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 38(8):917-920. (Pubitemid 44141660)
41. Crow YJ, Leitch A, Hayward BE, Garner A, Parmar R, Griffith E, Ali M, Semple C, Aicardi J, Babul-Hirji R, Baumann C, Baxter P, Bertini E, Chandler KE, Chitayat D, Cau D, Dery C, Fazzi E, Goizet C, King MD, Klepper J, Lacombe D, Lanzi G, Lyall H, Martinez-Frias ML, Mathieu M, McKeown C, Monier A, Oade Y, Quarrell OW, Rittey CD, Rogers RC, Sanchis A, Stephenson JB, Tacke U, Till M, Tolmie JL, Tomlin P, Voit T, Weschke B, Woods CG, Lebon P, Bonthron DT, Ponting CP, Jackson AP. 2006b. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 38(8):910-916. (Pubitemid 44141659)
42. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, Ahmed SA. 2010. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 5(12):e14302.
43. Daniel H, Kottra G. 2004. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch 447(5):610-618. (Pubitemid 38241445)
44. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S. 2007. Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27(5):801-810. (Pubitemid 350102256)
45. DeFilippis VR, Alvarado D, Sali T, Rothenburg S, Fruh K. 2010. Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1. J Virol 84(1):585-598.
46. Dell'Angelica EC. 2004. The building BLOC(k)s of lysosomes and related organelles. Curr Opin Cell Biol 16(4):458-464. (Pubitemid 38903153)
47. Dell'Angelica EC. 2009. AP-3-dependent trafficking and disease: the first decade. Curr Opin Cell Biol 21(4):552-559.
48. Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ, Valenzuela DM, Yancopoulos GD, Flavell RA, Alex-opoulou L. 2010. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 120(10):3651-3662.
49. Demirci FY, Manzi S, Ramsey-Goldman R, Kenney M, Shaw PS, Dunlop-Thomas CM, Kao AH, Rhew EY, Bontempo F, Kam-merer C, Kamboh MI. 2007. Association study of Toll-like receptor 5 (TLR5) and Toll-like receptor 9 (TLR9) polymorphisms in systemic lupus erythematosus. J Rheumatol 34(8):1708-1711. (Pubitemid 47267614)
50. Denny MF, Chandaroy P, Killen PD, Caricchio R, Lewis EE, Richardson BC, Lee KD, Gavalchin J, Kaplan MJ. 2006. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythema-tosus. J Immunol 176(4):2095-2104. (Pubitemid 43201656)
51. Dixit E, Boulant S, Zhang Y, Lee AS, Odendall C, Shum B, Hacohen N, Chen ZJ, Whelan SP, Fransen M, Nibert ML, Superti-Furga G, Kagan JC. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141(4):668-681.
52. Dombrowski Y, Peric M, Koglin S, Kammerbauer C, Goss C, Anz D, Simanski M, Glaser R, Harder J, Hornung V, Gallo RL, Ruzicka T, Besch R, Schauber J. 2011. Cytosolic DNA triggers inflammasome activation in keratinocytes in psoriatic lesions. Sci Transl Med 3(82):82-38.
53. Downes K, Pekalski M, Angus KL, Hardy M, Nutland S, Smyth DJ, Walker NM, Wallace C, Todd JA. 2010. Reduced expression of IFIH1 is protective for type 1 diabetes. PLoS One 5(9):pii:e12646.
54. Ewald SE, Engel A, Lee J, Wang M, Bogyo M, Barton GM. 2011. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopep-tidase. J Exp Med 208(4):643-651.
55. Ewald SE, Lee BL, Lau L, Wickliffe KE, Shi GP, Chapman HA, Barton GM. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456(7222): 658-662.
56. Fairhurst AM, Mathian A, Connolly JE, Wang A, Gray HF, George TA, Boudreaux CD, Zhou XJ, Li QZ, Koutouzov S, Banchereau J, Wakeland EK. 2008. Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice. Eur J Immunol 38(7):1948-1960.
57. Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458(7237):509-513.
58. Fitzgerald KA. 2011. The interferon inducible gene: Viperin. J Interferon Cytokine Res 31(1):131-135.
59. Frei R, Steinle J, Birchler T, Loeliger S, Roduit C, Steinhoff D, Seibl R, Buchner K, Seger R, Reith W, Lauener RP. 2010. MHC class II molecules enhance Toll-like receptor mediated innate immune responses. PLoS One 5(1):e8808.
60. Frisoni L, McPhie L, Kang SA, Monestier M, Madaio M, Satoh M, Caricchio R. 2007. Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies. J Immunol 179(11):7959-7966.
61. Fu Q, Zhao J, Qian X, Wong JL, Kaufman KM, Yu CY, Mok MY, Harley JB, Guthridge JM, Song YW, Cho SK, Bae SC, Grossman JM, Hahn BH, Arnett FC, Shen N, Tsao BP. 2011. Association of a functional IRF7 variant with systemic lupus erythematosus. Arthritis Rheum 63(3):749-754.
62. Fukui R, Saitoh S, Matsumoto F, Kozuka-Hata H, Oyama M, Tabeta K, Beutler B, Miyake K. 2009. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA-but against RNA-sensing. J Exp Med 206(6):1339-1350.
63. Fukui R, Saitoh SI, Kanno A, Onji M, Shibata T, Ito A, Matsu-moto M, Akira S, Yoshida N, Miyake K. 2011. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity 35(1):69-81.
64. Gack MU, Kirchhofer A, Shin YC, Inn KS, Liang C, Cui S, Myong S, Ha T, Hopfner KP, Jung JU. 2008. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc Natl Acad Sci USA 105(43):16743-16748.
65. Ganguly D, Chamilos G, Lande R, Gregorio J, Meller S, Facchi-netti V, Homey B, Barrat FJ, Zal T, Gilliet M. 2009. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. J Exp Med 206(9):1983-1994.
66. Garcia-Ortiz H, Velazquez-Cruz R, Espinosa-Rosales F, Jimenez-Morales S, Baca V, Orozco L. 2010. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis 69(10):1861-1865.
67. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3(73):73ra20.
68. Gay NJ, Gangloff M, O'Neill LA. 2011. What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol 32(3):104-109.
69. Hacker H, Mischak H, Miethke T, Liptay S, Schmid R, Spar-wasser T, Heeg K, Lipford GB, Wagner H. 1998. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 17(21):6230-6240. (Pubitemid 28497796)
70. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304(5674):1147-1150. (Pubitemid 38661849)
71. Hardin JA. 1986. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 29(4):457-460. (Pubitemid 16118693)
72. Harley IT, Kaufman KM, Langefeld CD, Harley JB, Kelly JA. 2009. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat Rev Genet 10(5):285-290.
73. Hassan GS, Mourad W. 2011. An unexpected role for MHC class II. Nat Immunol 12(5):375-376.
74. Hayakawa S, Shiratori S, Yamato H, Kameyama T, Kitatsuji C, Kashigi F, Goto S, Kameoka S, Fujikura D, Yamada T, Mizu-tani T, Kazumata M, Sato M, Tanaka J, Asaka M, Ohba Y, Miyazaki T, Imamura M, Takaoka A. 2011. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat Immunol 12(1):37-44.
75. Hirai M, Kadowaki N, Kitawaki T, Fujita H, Takaori-Kondo A, Fukui R, Miyake K, Maeda T, Kamihira S, Miyachi Y, Uchiyama T. 2011. Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Blood 117(2):500-509.
76. Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434(7036):1035-1040. (Pubitemid 40586053)
77. Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458(7237):514-518.
78. Hsing LC, Kirk EA, McMillen TS, Hsiao SH, Caldwell M, Houston B, Rudensky AY, LeBoeuf RC. 2010. Roles for ca-thepsins S, L, and B in insulitis and diabetes in the NOD mouse. J Autoimmun 34(2):96-104.
79. Hurtado P, Peh CA. 2010. LL-37 promotes rapid sensing of CpG oligodeoxynucleotides by B lymphocytes and plasmacytoid dendritic cells. J Immunol 184(3):1425-1435.
80. Imaizumi T, Arikawa T, Sato T, Uesato R, Matsumiya T, Yoshida H, Ueno M, Yamasaki S, Nakajima T, Hirashima M, Sakata K, Ishibashi Y, Toh S, Ohyama C, Satoh K. 2008. Involvement of retinoic acid-inducible gene-I in inflammation of rheumatoid fibroblast-like synoviocytes. Clin Exp Immunol 153(2):240-244. (Pubitemid 351989159)
81. Ishii KJ, Coban C, Kato H, Takahashi K, Torii Y, Takeshita F, Ludwig H, Sutter G, Suzuki K, Hemmi H, Sato S, Yamamoto M, Uematsu S, Kawai T, Takeuchi O, Akira S. 2006. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat Immunol 7(1):40-48. (Pubitemid 41823867)
82. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, Uematsu S, Takeuchi O, Takeshita F, Coban C, Akira S. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451(7179):725-729. (Pubitemid 351220566)
83. Ishikawa H, Barber GN. 2008. STING is an endoplasmic retic-ulum adaptor that facilitates innate immune signalling. Nature 455(7213):674-678.
84. Ishikawa H, Ma Z, Barber GN. 2009. STING regulates intracel-lular DNA-mediated, type I interferon-dependent innate immunity. Nature 461(7265):788-792.
85. Isnardi I, Ng YS, Srdanovic I, Motaghedi R, Rudchenko S, von Bernuth H, Zhang SY, Puel A, Jouanguy E, Picard C, Garty BZ, Camcioglu Y, Doffinger R, Kumararatne D, Davies G, Gallin JI, Haraguchi S, Day NK, Casanova JL, Meffre E. 2008. IRAK-4-and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29(5):746-757.
86. Ivanov S, Dragoi AM, Wang X, Dallacosta C, Louten J, Musco G, Sitia G, Yap GS, Wan Y, Biron CA, Bianchi ME, Wang H, Chu WM. 2007. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 110(6):1970-1981. (Pubitemid 47443911)
87. Jacob N, Guo S, Mathian A, Koss MN, Gindea S, Putterman C, Jacob CO, Stohl W. 2011. B Cell and BAFF dependence of IFN-{alpha}-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice. J Immunol 186(8):4984-4993.
88. Janssen E, Tabeta K, Barnes MJ, Rutschmann S, McBride S, Bahjat KS, Schoenberger SP, Theofilopoulos AN, Beutler B, Hoebe K. 2006. Efficient T cell activation via a Toll-Interleukin 1 Receptor-independent pathway. Immunity 24(6):787-799. (Pubitemid 43867366)
89. Jiang X, Chen ZJ. 2011. Viperin links lipid bodies to immune defense. Immunity 34(3):285-287.
90. Kavanagh D, Spitzer D, Kothari PH, Shaikh A, Liszewski MK, Richards A, Atkinson JP. 2008. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle 7(12): 1718-1725. (Pubitemid 351988737)
91. Kawaguchi S, Ishiguro Y, Imaizumi T, Mori F, Matsumiya T, Yoshida H, Ota K, Sakuraba H, Yamagata K, Sato Y, Tanji K, Haga T, Wakabayashi K, Fukuda S, Satoh K. 2009. Retinoic acid-inducible gene-I is constitutively expressed and involved in IFN-gamma-stimulated CXCL9-11 production in intestinal epithelial cells. Immunol Lett 123(1):9-13.
92. Kawai T, Akira S. 2006. TLR signaling. Cell Death Differ 13(5):816-825.
93. Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N. 2011. TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther 13(2):R41.
94. Kelley J, Johnson MR, Alarcon GS, Kimberly RP, Edberg JC. 2007. Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects. Arthritis Rheum 56(10):3375-3378. (Pubitemid 47585432)
95. Kenny EF, O'Neill LA. 2008. Signalling adaptors used by Tolllike receptors: an update. Cytokine 43(3):342-349.
96. Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B. 2011. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe 9(5):363-375.
97. Kessenbrock K, Krumbholz M, Schonermarck U, Back W, Gross WL, Werb Z, Grone HJ, Brinkmann V, Jenne DE. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15(6):623-625.
98. Kim MJ, Yoo JY. 2008. Active caspase-1-mediated secretion of retinoic acid inducible gene-I. J Immunol 181(10):7324-7331.
99. Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J, Liu YJ. 2010. Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase a helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci USA 107(34):15181-15186.
100. Kimkong I, Avihingsanon Y, Hirankarn N. 2009. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR. Lupus 18(12):1066-1072.
101. Kimkong I, Avihingsanon Y, Hirankarn N. 2010. Association of IFI200 gene polymorphisms with susceptibility to systemic lupus erythematosus. J Rheumatol 37(7):1544-1547.
102. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. 2005. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 52(5):1491-1503. (Pubitemid 40663941)
103. Kitamura H, Matsuzaki Y, Kimura K, Nakano H, Imaizumi T, Satoh K, Hanada K. 2007. Cytokine modulation of retinoic acid-inducible gene-I (RIG-I) expression in human epidermal keratinocytes. J Dermatol Sci 45(2):127-134. (Pubitemid 46108490)
104. Kok KH, Lui PY, Ng MH, Siu KL, Au SW, Jin DY. 2011. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9(4):299-309.
105. Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, Arnold CN, Baccala R, Silverman GJ, Beutler BA, Theofilo-poulos AN. 2009. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci USA 106(29):12061-12066.
106. Koshiba T, Yasukawa K, Yanagi Y, Kawabata S. 2011. Mi-tochondrial membrane potential is required for MAVS-medi-ated antiviral signaling. Sci Signal 4(158):ra7.
107. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M. 2011. Neu-trophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3(73):73ra19.
108. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, Zal T, Mellman I, Schroder JM, Liu YJ, Gilliet M. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449(7162):564-569. (Pubitemid 47525141)
109. Lang T, Mansell A. 2007. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 85(6):425-434. (Pubitemid 47367504)
110. Latz E, Verma A, Visintin A, Gong M, Sirois CM, Klein DC, Monks BG, McKnight CJ, Lamphier MS, Duprex WP, Espevik T, Golenbock DT. 2007. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8(7):772-779. (Pubitemid 46965353)
111. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416(6881):603-607. (Pubitemid 34406754)
112. Lech M, Kulkarni OP, Pfeiffer S, Savarese E, Krug A, Garlanda C, Mantovani A, Anders HJ. 2008. Tir8/Sigirr prevents mu-rine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J Exp Med 205(8):1879-1888.
113. Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, de Silva U, Bailey SL, Witte T, Vyse TJ, Kere J, Pfeiffer C, Harvey S, Wong A, Koskenmies S, Hummel O, Rohde K, Schmidt RE, Dominiczak AF, Gahr M, Hollis T, Perrino FW, Lieberman J, Hubner N. 2007. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 39(9):1065-1067. (Pubitemid 47340647)
114. Lemke G, Rothlin CV. 2008. Immunobiology of the TAM receptors. Nat Rev Immunol 8(5):327-336. (Pubitemid 351595219)
115. Lewis MJ, Botto M. 2006. Complement deficiencies in humans and animals: links to autoimmunity. Autoimmunity 39(5): 367-378. (Pubitemid 44269614)
116. Lin SC, Lo YC, Wu H. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465(7300):885-890.
117. Liu F, Gu J. 2011. Retinoic acid inducible gene-I, more than a virus sensor. Protein Cell 2(5):351-357.
118. Liu F, Wu S, Ren H, Gu J. 2011a. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol 13(3):254-262.
119. Liu HM, Gale M, Jr. 2011. ZAPS electrifies RIG-I signaling. Nat Immunol 12(1):11-12.
120. Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P, Yao H, Cao X. 2011b. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol 12(5):416-424.
121. Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A. 2011c. Interferon-alpha accelerates murine systemic lupus erythematosus in a T cell-dependent manner. Arthritis Rheum 63(1):219-229.
122. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34(5):680-692.
123. Lu Q, Lemke G. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293(5528):306-311. (Pubitemid 32694748)
124. Maehr R, Mintern JD, Herman AE, Lennon-Dumenil AM, Ma-this D, Benoist C, Ploegh HL. 2005. Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. J Clin Invest 115(10):2934-2943. (Pubitemid 41434421)
125. Mantovani A, Cassatella MA, Costantini C, Jaillon S. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11(8):519-531.
126. Marshak-Rothstein A, Rifkin IR. 2007. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol 25:419-441. (Pubitemid 46697913)
127. Mathian A, Gallegos M, Pascual V, Banchereau J, Koutouzov S. 2011. Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZBxNZW)F1 mice but not in BALB/c mice. Eur J Immunol 41(3):863-872.
128. Mathian A, Weinberg A, Gallegos M, Banchereau J, Koutouzov S. 2005. IFN-alpha induces early lethal lupus in pre-autoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice. J Immunol 174(5):2499-2506. (Pubitemid 40279662)
129. Matsumiya T, Stafforini DM. 2010. Function and regulation of retinoic acid-inducible gene-I. Crit Rev Immunol 30(6):489-513.
130. Matsumoto F, Saitoh S, Fukui R, Kobayashi T, Tanimura N, Konno K, Kusumoto Y, Akashi-Takamura S, Miyake K. 2008. Cathepsins are required for Toll-like receptor 9 responses. Biochem Biophys Res Commun 367(3):693-699.
131. Mattera R, Boehm M, Chaudhuri R, Prabhu Y, Bonifacino JS. 2011. Conservation and diversification of dileucine signal recognition by adaptor protein (AP) complex variants. J Biol Chem 286(3):2022-2030.
132. McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Cal-deron B, Gilfillan S, Diamond MS, Unanue ER, Colonna M. RNA sensor-induced type I IFN prevents diabetes caused by a beta cell-tropic virus in mice. J Clin Invest 121(4):1497-1507.
133. Mevorach D, Zhou JL, Song X, Elkon KB. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188(2):387-392. (Pubitemid 28357766)
134. Monroe JG, Keir ME. 2008. Bridging Toll-like-and B cell-receptor signaling: meet me at the autophagosome. Immunity 28(6): 729-731. (Pubitemid 351778414)
135. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD, Heise MT, Chen Z, Ting JP. 2008. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451(7178):573-577. (Pubitemid 351186265)
136. Moore CB, Ting JP. 2008. Regulation of mitochondrial antiviral signaling pathways. Immunity 28(6):735-739. (Pubitemid 351778413)
137. Moresco EM, Beutler B. 2010. LGP2: positive about viral sensing. Proc Natl Acad Sci USA 107(4):1261-1262.
138. Moresco EM, Beutler B. 2011. Special delivery: granulin brings CpG DNA to Toll-like receptor 9. Immunity 34(4):453-455.
139. Moresco EM, Lavine D, Beutler B. 2011. Toll-like receptors. Curr Biol 21(13):R488-493.
140. Motshwene PG, Moncrieffe MC, Grossmann JG, Kao C, Ayaluru M, Sandercock AM, Robinson CV, Latz E, Gay NJ. 2009. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem 284(37): 25404-25411.
141. Mukundan L, Odegaard JI, Morel CR, Heredia JE, Mwangi JW, Ricardo-Gonzalez RR, Goh YP, Eagle AR, Dunn SE, Awakuni JU, Nguyen KD, Steinman L, Michie SA, Chawla A. 2009. PPAR-delta senses and orchestrates clearance of apoptotic cells to promote tolerance. Nat Med 15(11):1266-1272.
142. Munoz LE, Janko C, Schulze C, Schorn C, Sarter K, Schett G, Herrmann M. 2010. Autoimmunity and chronic inflammation-two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 10(1):38-42.
143. Muruve DA, Petrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, Tschopp J. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452(7183):103-107. (Pubitemid 351355095)
144. Nagata S. 2008. Rheumatoid polyarthritis caused by a defect in DNA degradation. Cytokine Growth Factor Rev 19(3-4):295-302.
145. Nagpal K, Plantinga TS, Sirois CM, Monks BG, Latz E, Netea MG, Golenbock DT. 2011. Natural loss-of-function mutation of myeloid differentiation protein 88 disrupts its ability to form Myddosomes. J Biol Chem 286(13):11875-11882.
146. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25(2):177-181. (Pubitemid 30394988)
147. Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324(5925): 387-389.
148. Neubert K, Meister S, Moser K, Weisel F, Maseda D, Amann K, Wiethe C, Winkler TH, Kalden JR, Manz RA, Voll RE. 2008. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 14(7):748-755. (Pubitemid 351951516)
149. Nickerson KM, Christensen SR, Shupe J, Kashgarian M, Kim D, Elkon K, Shlomchik MJ. 2010. TLR9 regulates TLR7-and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 184(4):1840-1848.
150. Nielsen CU, Brodin B. 2003. Di/tri-peptide transporters as drug delivery targets: regulation of transport under physiological and patho-physiological conditions. Curr Drug Targets 4(5):373-388. (Pubitemid 36758317)
151. Nikpour M, Dempsey AA, Urowitz MB, Gladman DD, Barnes DA. 2008. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis 67(8):1069-1075.
152. Obermoser G, Pascual V. 2010. The interferon-alpha signature of systemic lupus erythematosus. Lupus 19(9):1012-1019.
153. Onoguchi K, Onomoto K, Takamatsu S, Jogi M, Takemura A, Morimoto S, Julkunen I, Namiki H, Yoneyama M, Fujita T. 2010. Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1. PLoS Pathog 6(7):e1001012.
154. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. 2009. Riplet/RNF135, a RING finger protein, Ubiquitinates RIG-I to promote interferon-{beta} induction during the early phase of viral infection. J Biol Chem 284(2):807-817.
155. Panchanathan R, Duan X, Shen H, Rathinam VA, Erickson LD, Fitzgerald KA, Choubey D. 2010. Aim2 deficiency stimulates the expression of IFN-inducible Ifi202, a lupus susceptibility murine gene within the Nba2 autoimmune susceptibility locus. J Immunol 185(12):7385-7393.
156. Panchanathan R, Shen H, Duan X, Rathinam VA, Erickson LD, Fitzgerald KA, Choubey D. 2011. Aim2 deficiency in mice suppresses the expression of the inhibitory Fc{gamma} receptor (Fc{gamma}RIIB) through the induction of the IFN-Inducible p202, a lupus susceptibility protein. J Immunol 186(12):6762-6770.
157. Pao LI, Lam KP, Henderson JM, Kutok JL, Alimzhanov M, Nitschke L, Thomas ML, Neel BG, Rajewsky K. 2007. B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic auto-immunity. Immunity 27(1):35-48. (Pubitemid 47089020)
158. Park B, Brinkmann MM, Spooner E, Lee CC, Kim YM, Ploegh HL. 2008. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 9(12):1407-1414.
159. Park B, Buti L, Lee S, Matsuwaki T, Spooner E, Brinkmann MM, Nishihara M, Ploegh HL. 2011. Granulin is a soluble cofactor for Toll-like receptor 9 signaling. Immunity 34(4):505-513.
160. Paul E, Carroll MC. 1999. SAP-less chromatin triggers systemic lupus erythematosus. Nat Med 5(6):607-608. (Pubitemid 29289414)
161. Pauley KM, Cha S, Chan EK. 2009. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 32(3-4):189-194.
162. Perrino FW, Harvey S, Shaban NM, Hollis T. 2009. RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases. J Mol Med 87(1):25-30.
163. Petri M, Singh S, Tesfasyone H, Dedrick R, Fry K, Lal P, Williams G, Bauer J, Gregersen P, Behrens T, Baechler E. 2009. Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus 18(11):980-989.
164. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis ESC. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5' phosphates. Science 314(5801):997-1001. (Pubitemid 44749946)
165. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312(5780):1669-1672. (Pubitemid 43902669)
166. Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschlager N, Schlee M, Rothenfusser S, Barchet W, Kato H, Akira S, Inoue S, Endres S, Peschel C, Hartmann G, Hor-nung V, Ruland J. 2010. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nat Immunol 11(1):63-69.
167. Poole BD, Scofield RH, Harley JB, James JA. 2006. Epstein-Barr virus and molecular mimicry in systemic lupus erythema-tosus. Autoimmunity 39(1):63-70. (Pubitemid 43878521)
168. Prens EP, Kant M, van Dijk G, van der Wel LI, Mourits S, van der Fits L. 2008. IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis. J Invest Dermatol 128(4):932-938. (Pubitemid 351374290)
169. Rajput A, Kovalenko A, Bogdanov K, Yang SH, Kang TB, Kim JC, Du J, Wallach D. 2011. RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein. Immunity 34(3): 340-351.
170. Ramanujam M, Kahn P, Huang W, Tao H, Madaio MP, Factor SM, Davidson A. 2009. Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation. Arthritis Rheum 60(4): 1096-1101.
171. Randow F, Seed B. 2001. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat Cell Biol 3(10):891-896. (Pubitemid 32952253)
172. Rice GI, Bond J, Asipu A, Brunette RL, Manfield IW, Carr IM, Fuller JC, Jackson RM, Lamb T, Briggs TA, Ali M, Gornall H, Couthard LR, Aeby A, Attard-Montalto SP, Bertini E, Bode-mer C, Brockmann K, Brueton LA, Corry PC, Desguerre I, Fazzi E, Cazorla AG, Gener B, Hamel BC, Heiberg A, Hunter M, van der Knaap MS, Kumar R, Lagae L, Landrieu PG, Lourenco CM, Marom D, McDermott MF, van der Merwe W, Orcesi S, Prendiville JS, Rasmussen M, Shalev SA, Soler DM, Shinawi M, Spiegel R, Tan TY, Vanderver A, Wakeling EL, Wassmer E, Whittaker E, Lebon P, Stetson DB, Bonthron DT, Crow YJ. 2009. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nat Genet 41(7):829-832.
173. Riemekasten G, Hahn BH. 2005. Key autoantigens in SLE. Rheumatology 44(8):975-982. (Pubitemid 41487168)
174. Rintahaka J, Wiik D, Kovanen PE, Alenius H, Matikainen S. 2008. Cytosolic antiviral RNA recognition pathway activates caspases 1 and 3. J Immunol 180(3):1749-1757.
175. Roberts TL, IdrisA, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, Hume DA, Stacey KJ. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323(5917):1057-1060.
176. Ronnblom L, Eloranta ML, Alm GV. 2006. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum 54(2):408-420. (Pubitemid 43228615)
177. Rothlin CV, Ghosh S, Zuniga EI, Oldstone MB, Lemke G. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131(6):1124-1136. (Pubitemid 350235020)
178. Rozzo SJ, Allard JD, Choubey D, Vyse TJ, Izui S, Peltz G, Kotzin BL. 2001. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15(3):435-443. (Pubitemid 32907390)
179. Ruan BH, Li X, Winkler AR, Cunningham KM, Kuai J, Greco RM, Nocka KH, Fitz LJ, Wright JF, Pittman DD, Tan XY, Paulsen JE, Lin LL, Winkler DG. 2010. Complement C3a, CpG oligos, and DNA/C3a complex stimulate IFN-alpha production in a receptor for advanced glycation end product-dependent manner. J Immunol 185(7):4213-4222.
180. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, Bose S. 2009. Activation of innate immune antiviral responses by Nod2. Nat Immunol 10(10):1073-1080.
181. Saegusa K, Ishimaru N, Yanagi K, Arakaki R, Ogawa K, Saito I, Katunuma N, Hayashi Y. 2002. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J Clin Invest 110(3):361-369. (Pubitemid 34847968)
182. Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, Matsunaga K, Kageyama S, Omori H, Noda T, Yamamoto N, Kawai T, Ishii K, Takeuchi O, Yoshimori T, Akira S. 2009. Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci USA 106(49):20842-20846.
183. Saitoh T, Satoh T, Yamamoto N, Uematsu S, Takeuchi O, Kawai T, Akira S. 2011. Antiviral protein Viperin promotes Toll-like receptor 7-and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 34(3): 352-363.
184. Sanchez E, Callejas-Rubio JL, Sabio JM, Gonzalez-Gay MA, Ji-menez-Alonso J, Mico L, de Ramon E, Camps M, Suarez A, Gutierrez C, Garcia-Portales R, Tolosa C, Ortego-Centeno N, Sanchez-Roman J, Garcia-Hernandez FJ, Gonzalez-Escribano MF, Martin J. 2009. Investigation of TLR5 and TLR7 as candidate genes for susceptibility to systemic lupus er-ythematosus. Clin Exp Rheumatol 27(2):267-271.
185. Santiago-Raber ML, Baccala R, Haraldsson KM, Choubey D, Stewart TA, Kono DH, Theofilopoulos AN. 2003. Type-I in-terferon receptor deficiency reduces lupus-like disease in NZB mice. J Exp Med 197(6):777-788. (Pubitemid 36350872)
186. Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S. 2010. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun 34(4):339-348.
187. Santiago-Raber ML, Kikuchi S, Borel P, Uematsu S, Akira S, Kotzin BL, Izui S. 2008. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus. J Immunol 181(2):1556-1562.
188. Sasai M, Linehan MM, Iwasaki A. 2010. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329(5998): 1530-1534.
189. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O. 2010. LGP2 is a positive regulator of RIG-I-and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 107(4):1512-1517.
190. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418(6894):191-195. (Pubitemid 34773774)
191. Schlee M, Hartmann E, Coch C, Wimmenauer V, Janke M, Barchet W, Hartmann G. 2009. Approaching the RNA ligand for RIG-I? Immunol Rev 227(1):66-74.
192. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bi-eniasz P, Rice CM. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472(7344):481-485.
193. Schorlemmer HU, Kanzy EJ, Langner KD, Kurrle R. 1993. Immunoregulation of SLE-like disease by the IL-1 receptor: disease modifying activity on BDF1 hybrid mice and MRL autoimmune mice. Agents Actions 39 Spec No:C117-120. (Pubitemid 23276745)
194. Schulz O, Pichlmair A, Rehwinkel J, Rogers NC, Scheuner D, Kato H, Takeuchi O, Akira S, Kaufman RJ, Reis e Sousa C. 2010. Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. Cell Host Microbe 7(5):354-361.
195. Sepulveda FE, Maschalidi S, Colisson R, Heslop L, Ghirelli C, Sakka E, Lennon-Dumenil AM, Amigorena S, Cabanie L, Manoury B. 2009. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31(5):737-748.
196. Sharma S, Fitzgerald KA. 2011. Innate immune sensing of DNA. PLoS Pathog 7(4):e1001310.
197. Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, Yang W, Wong M, Kawasaki A, Tsuchiya N, Sumida T, Kawaguchi Y, Howe HS, Mok MY, Bang SY, Liu FL, Chang DM, Takasaki Y, Hashimoto H, Harley JB, Guthridge JM, Grossman JM, Cantor RM, Song YW, Bae SC, Chen S, Hahn BH, Lau YL, Tsao BP. 2010. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA 107(36):15838-15843.
198. Shigemoto T, Kageyama M, Hirai R, Zheng J, Yoneyama M, Fujita T. 2009. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem 284(20):13348-13354.
199. Stack J, Haga IR, Schroder M, Bartlett NW, Maloney G, Reading PC, Fitzgerald KA, Smith GL, Bowie AG. 2005. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201(6):1007-1018. (Pubitemid 40524469)
200. Stetson DB, Ko JS, Heidmann T, Medzhitov R. 2008. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134(4): 587-598.
201. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24(1):93-103. (Pubitemid 43077203)
202. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J, Liang C, Bartov G, McDaniel LD, Zhou XJ, Schultz RA, Wakeland EK. 2006. A Tlr7 translocation accelerates systemic auto-immunity in murine lupus. Proc Natl Acad Sci USA 103(26):9970-9975. (Pubitemid 43993607)
203. Tabeta K, Hoebe K, Janssen EM, Du X, Georgel P, Crozat K, Mudd S, Mann N, Sovath S, Goode J, Shamel L, Herskovits AA, Portnoy DA, Cooke M, Tarantino LM, Wiltshire T, Steinberg BE, Grinstein S, Beutler B. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 7(2):156-164. (Pubitemid 43135881)
204. Tada Y, Kondo S, Aoki S, Koarada S, Inoue H, Suematsu R, Ohta A, Mak TW, Nagasawa K. 2011. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. Arthritis Rheum 63(3):738-748.
205. Takahashi K, Shibata T, Akashi-Takamura S, Kiyokawa T, Wa-kabayashi Y, Tanimura N, Kobayashi T, Matsumoto F, Fukui R, Kouro T, Nagai Y, Takatsu K, Saitoh S, Miyake K. 2007. A protein associated with Toll-like receptor (TLR) 4 (PRAT4A) is required for TLR-dependent immune responses. J Exp Med 204(12):2963-2976. (Pubitemid 350179564)
206. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kodama T, Honda K, Ohba Y, Taniguchi T. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448(7152):501-505. (Pubitemid 47123520)
207. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, Summer RS, Kihara S, Walsh K. 2007. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest 117(2):375-386. (Pubitemid 46203966)
208. Takeuchi O, Akira S. 2008. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20(1):17-22.
209. Tan EM. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93-151. (Pubitemid 19090837)
210. Taneichi-Kuroda S, Taya S, Hikita T, Fujino Y, Kaibuchi K. 2009. Direct interaction of Dysbindin with the AP-3 complex via its mu subunit. Neurochem Int 54(7):431-438.
211. Tang Y, Luo X, Cui H, Ni X, Yuan M, Guo Y, Huang X, Zhou H, de Vries N, Tak PP, Chen S, Shen N. 2009. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 60(4):1065-1075.
212. Theofilopoulos AN, Baccala R, Beutler B, Kono DH. 2005. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23:307-335.
213. Theofilopoulos AN, Dixon FJ. 1985. Murine models of systemic lupus erythematosus. Adv Immunol 37:269-390. (Pubitemid 15093080)
214. Theofilopoulos AN, Gonzalez-Quintial R, Lawson BR, Koh YT, Stern ME, Kono DH, Beutler B, Baccala R. 2010. Sensors of the innate immune system: their link to rheumatic diseases. Nat Rev Rheumatol 6(3):146-156.
215. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ. 2007. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8(5):487-196.
216. Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G, Kal-liolias GD, Ramanujam M, van Rooijen N, Davidson A, Ivashkiv LB. 2010. Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I inter-ferons and macrophages. Proc Natl Acad Sci USA 107(7):3012-3017.
217. Uematsu S, Akira S. 2006. Toll-like receptors and innate immunity. J Mol Med 84(9):712-725. (Pubitemid 44328063)
218. Ullal AJ, Reich CF, 3rd, Clowse M, Criscione-Schreiber LG, To-chacek M, Monestier M, Pisetsky DS. 2011. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 36(3-4):173-180.
219. Unterholzner L, Bowie AG. 2011. Innate DNA sensing moves to the nucleus. Cell Host Microbe 9(5):351-353.
220. Unterholzner L, Keating SE, Baran M, Horan KA, Jensen SB, Sharma S, Sirois CM, Jin T, Latz E, Xiao TS, Fitzgerald KA, Paludan SR, Bowie AG. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 11(11):997-1004.
221. Urbonaviciute V, Voll RE. 2011. HMGB1 represents a potential marker of disease activity and novel therapeutic target in SLE. J Intern Med 270(4):309-318.
222. Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19(6):837-847. (Pubitemid 37542304)
223. Vinuesa CG, Rigby RJ, Yu D. 2009. Logic and extent of miRNA-mediated control of autoimmune gene expression. Int Rev Immunol 28(3-4):112-138.
224. Viorritto IC, Nikolov NP, Siegel RM. 2007. Autoimmunity versus tolerance: can dying cells tip the balance? Clin Immunol 122(2):125-134. (Pubitemid 46073889)
225. Wang J, Shao Y, Bennett TA, Shankar RA, Wightman PD, Reddy LG. 2006. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J Biol Chem 281(49):37427-37434. (Pubitemid 46042046)
226. Wang Z, Choi MK, Ban T, Yanai H, Negishi H, Lu Y, Tamura T, Takaoka A, Nishikura K, Taniguchi T. 2008. Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules. Proc Natl Acad Sci USA 105(14):5477-5482. (Pubitemid 351753888)
227. Watters TM, Kenny EF, O'Neill LA. 2007. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol 85(6):411-419. (Pubitemid 47367505)
228. Wu X, Peng SL. 2006. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 54(1):336-342. (Pubitemid 43122217)
229. Xia X, Cui J, Wang HY, Zhu L, Matsueda S, Wang Q, Yang X, Hong J, Songyang Z, Chen ZJ, Wang RF. 2011. NLRX1 negatively regulates TLR-Induced NF-kappaB signaling by targeting TRAF6 and IKK. Immunity 34(6):843-853.
230. Xiao C, Rajewsky K. 2009. MicroRNA control in the immune system: basic principles. Cell 136(1):26-36.
231. Yamashita T, Shimada S, Guo W, Sato K, Kohmura E, Haya-kawa T, Takagi T, Tohyama M. 1997. Cloning and functional expression of a brain peptide/histidine transporter. J Biol Chem 272(15):10205-10211. (Pubitemid 27171699)
232. Yanai H, Ban T, Taniguchi T. 2011. Essential role of HMGB proteins in nucleic acid-mediated innate immune responses. J Intern Med 270(4):301-308.
233. Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S, Bianchi ME, Honda K, Tamura T, Kodama T, Taniguchi T. 2009. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462(7269):99-103.
234. Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, Cao X. 2010. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 11(6):487-494.
235. Yang Y, Liu B, Dai J, Srivastava PK, Zammit DJ, Lefrancois L, Li Z. 2007a. Heat shock protein gp96 is a master chaperone for Toll-like receptors and is important in the innate function of macrophages. Immunity 26(2):215-226. (Pubitemid 46329432)
236. Yang YG, Lindahl T, Barnes DE. 2007b. Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131(5):873-886. (Pubitemid 350138088)
237. Yasutomo K, Horiuchi T, Kagami S, Tsukamoto H, Hashimura C, Urushihara M, Kuroda Y. 2001. Mutation of DNASE1 in people with systemic lupus erythematosus. Nat Genet 28(4): 313-314. (Pubitemid 32702418)
238. Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227(1): 54-65.
239. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, Chen ZJ. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141(2):315-330.
240. Zhang X, Brann TW, Zhou M, Yang J, Oguariri RM, Lidie KB, Imamichi H, Huang DW, Lempicki RA, Baseler MW, Veenstra TD, Young HA, Lane HC, Imamichi T. 2011. Cutting edge: Ku70 is a novel cytosolic DNA sensor that induces type III rather than type I IFN. J Immunol 186(8):4541-4545.
241. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F, Lei C, He X, Zhang L, Tien P, Shu HB. 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29(4):538-550.